We are live on ! Find out more
VCYT icon

Veracyte

240 hedge funds and large institutions have $1.78B invested in Veracyte in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 90 increasing their positions, 85 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $966K | Put options by funds: $417K

6% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 85

2% less capital invested

Capital invested by funds: $1.82B → $1.78B (-$38.1M)

1.9% less ownership

Funds ownership: 109.34%107.44% (-1.9%)

2% less funds holding

Funds holding: 246240 (-6)

10% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 29

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
240
Holders Change
-6
Holders Change %
-2.44%
% of All Funds
3.47%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
26
Increased
90
Reduced
85
Closed
29
Calls
$966K
Puts
$417K
Net Calls
+$549K
Net Calls Change
+$1.43M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$169M +$12.2M +581,688 +8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$162M +$2.36M +112,110 +2%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$149M -$10.3M -491,279 -7%
AIM
4
ARK Investment Management
Florida
$148M -$4.91M -233,486 -3%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$75M -$78K -3,708 -0.1%
Sumitomo Mitsui Trust Group
6
Sumitomo Mitsui Trust Group
Japan
$68.9M -$3.49M -165,844 -5%
NAMA
7
Nikko Asset Management Americas
New York
$68.9M -$3.49M -165,844 -5%
CIP
8
Champlain Investment Partners
Vermont
$68.6M +$9.88M +470,070 +17%
Artisan Partners
9
Artisan Partners
Wisconsin
$66.4M -$340K -16,154 -0.5%
ACH
10
ArrowMark Colorado Holdings
Colorado
$65M +$7.45M +354,538 +13%
State Street
11
State Street
Massachusetts
$63M -$29.8M -1,418,432 -33%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$39.6M +$2.66M +126,486 +7%
Bank of America
13
Bank of America
North Carolina
$38.9M +$5.8M +275,772 +18%
GKIM
14
GW&K Investment Management
Massachusetts
$30.5M +$204K +9,683 +0.7%
William Blair Investment Management
15
William Blair Investment Management
Illinois
$26.9M +$10.5M +500,020 +67%
BAMCO Inc
16
BAMCO Inc
New York
$24.4M +$210K +10,000 +0.9%
Goldman Sachs
17
Goldman Sachs
New York
$23.6M +$2.4M +114,111 +12%
GIP
18
Granite Investment Partners
California
$20.3M +$405K +19,244 +2%
Northern Trust
19
Northern Trust
Illinois
$20.2M -$748K -35,572 -4%
Fisher Asset Management
20
Fisher Asset Management
Washington
$19.3M +$154K +7,340 +0.8%
New York State Common Retirement Fund
21
New York State Common Retirement Fund
New York
$19.3M +$551K +26,214 +3%
CC
22
Casdin Capital
New York
$18.6M
ECM
23
ExodusPoint Capital Management
New York
$17.3M +$13.7M +650,646 +440%
Charles Schwab
24
Charles Schwab
California
$16.5M +$616K +29,322 +4%
AAMU
25
AEGON Asset Management (UK)
United Kingdom
$16.4M +$7.53M +358,001 +89%

VCYT Hedge Fund Activity: Q2 2024 in Review

240 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2024, worth a combined $1.78B — down 2.1% from $1.82B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of VCYT and 26 opened new positions — a net loss of 3 holders — while 85 trimmed existing stakes and 90 added.

The largest buyer was ExodusPoint Capital Management, adding an estimated $13.7M. The largest seller was State Street, cutting an estimated $29.8M.

  • 240 institutional investors held Veracyte (VCYT) as of Q2 2024, down from 246 in Q1 2024.
  • Funds reported $1.78B of Veracyte stock for Q2 2024, down 2.1% quarter-over-quarter.
  • 26 funds opened new Veracyte positions in Q2 2024 and 29 closed out, a net change of -3 holders.
  • The largest Veracyte buyer in Q2 2024 was ExodusPoint Capital Management, an estimated $13.7M added.
  • The largest Veracyte seller in Q2 2024 was State Street, an estimated $29.8M sold.

Based on aggregated 13F filings for Q2 2024.